Rapid Advice: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants
Get This Resource
English: Web Page
Summary
Since the 2006 WHO recommendations on PMTCT, several clinical trials have shown the efficacy of ARVs in preventing transmission to the infant while breastfeeding. The 2009 recommendations promote the use of ARVs earlier in pregnancy, starting at 14 weeks and continuing through the end of the breastfeeding period. WHO now recommends that breastfeeding continue until the infant is 12 months of age, provided the HIV-positive mother or baby is taking ARVs during that period. This will reduce the risk of HIV transmission and improve the infant's chance of survival.
Related Resources
- Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents
- Rapid Advice: WHO Principles and Recommendations on Infant Feeding in the Context of HIV
|
|
World Health Organization |
|
|
English |
|
|
Web Page |
|
|
Global |
|
|
Doctors/Physicians, Physician's Assistants/Nurse Practitioners, Policymakers |
|
|
Perinatal Interventions, Antiretroviral Treatment & Complications, General Care during Pregnancy, Labor, & Delivery |
|
|
Clinical Guidelines |
